获得的无形性贫血治疗方法:免疫抑制疗法与替代捐赠者造血细胞移植相比
1Cellular Immunotherapies and Transplant Program, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23219, USA.
Journal of hematology
|July 12, 2024
概括
针对严重的无形成性贫血的免疫抑制疗法带有复发和骨髓瘤的风险,特别是在老年人中. 替代性捐赠干细胞移植的进展可能为这些患者提供更好的前期治疗选择.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 获得性严重无形性贫血 (SAA) 免疫抑制疗法 (IST) 治疗改善了全细胞衰减,但具有高复发 (40%) 和克隆进化 (15%) 的风险.
- 患有SAA的老年患者 (>40岁) 面临IST的特殊挑战,但目前的指导方针偏好它而不是治疗选择.
- 治愈性全基性干细胞移植 (SCT) 通常保留给具有匹配兄弟捐赠者的年轻患者,限制了获得.
研究的目的:
- 审查SAA.替代性供体血造细胞移植 (HCT) 的最新进展.
- 讨论这些进展如何改变目前SAA患者,特别是老年人的治疗指南.
- 突出提前替代捐赠体HCT作为治愈方法的潜力.
主要方法:
- 审查改变实践的数据和对SAA的替代供体HCT的最新进展.
- 对接受前期替代供体HCT的患者的结果分析.
- 在SAA治疗算法中,IST与替代供体HCT的比较.
主要成果:
- 针对SAA的IST导致复发和转化为髓质瘤瘤的重大风险.
- 目前的指导方针将治愈性前期全原性SCT限制在一个狭窄的患者子集中.
- 新出现的数据支持替代捐助国HCT作为SAA的可行预先战略.
结论:
- 前期替代供体HCT为SAA患者,特别是40岁以上的患者提供了一种有前途的IST替代方案.
- 在HCT的近期进展正在挑战SAA的现有治疗模式.
- 需要新的治疗算法,包括替代供体HCT,以改善SAA患者的治疗结果.
相关概念视频
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323
Cell-mediated Immune Responses
68.0K
Overview
68.0K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Tissue Transplantation
354
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
354
Immunodeficiency Diseases
933
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
933


